ORCA-3 Phase 3 Trial Reports Statistically Significant Topline Efficacy Results in Smoking Cessation
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
05/11/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/27/22 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
67 |
04/21/22 | DEF 14A | Definitive proxy statements |
![]() |
37 | |
04/05/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
03/16/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 |